Neuland Laboratories Limited (NEULANDLAB) — Announcement | 5 August 2026 (2 announcements)

5 August 2026 · NSE Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Announcement Neutral📄 PDF

📢 Key Event

Audio recording of earnings call made available

💡 Investor Takeaway

Shareholders can now access the full discussion of recent results.

Neuland Laboratories announced an audio recording of its August 5, 2026 earnings call for Q1 FY27, accessible via its investor portal, to comply with SEBI disclosure norms.

2Announcement Neutral📄 PDF

📢 Key Event

Board approves Q1 results and 40 crore guarantee for Gland Pharma capacity expansion

🔄 What Changed

40 crore guarantee approved; 18 KL capacity addition planned

🔮 What's Next

Capacity addition to be completed within 6-7 months

💡 Investor Takeaway

The guarantee creates contingent liability but enables critical sterile API manufacturing expansion.

Neuland Laboratories announced on August 5, 2026, that its board approved unaudited financial results for Q1 June 2026 and a 40 crore rupee corporate guarantee for Gland Pharma to fund dedicated manufacturing capacity expansion. The company also disclosed plans to add 18 KL capacity at Unit 1 in Bonthapally, requiring 39.8 crore rupees investment through internal accruals. The filing includes auditor review reports confirming compliance with SEBI regulations and no material misstatements in the financials.

📊 Stock Analysis — NEULANDLAB ✨ Ask AI About This

About Neuland Laboratories Limited (NEULANDLAB)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹27,498.49 CrP/E: 55.2ROE: 26.6%ROCE: 33.6%Div Yield: 0.16%

View full NEULANDLAB stock details →

📡 Get AI alerts when NEULANDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NEULANDLAB — Free

💡 Ask AI about this filing

"When will the transcript be published?""What were the key Q1 performance metrics?""How does management view FY27 margins?"

Ask AI Free →

📊 More NEULANDLAB filings

Announcement — 25 September 2026Neuland Laboratories has closed its insider trading window effective October 1, 2026, until 48 hours...
🔴 Announcement — 16 September 2026Neuland Laboratories announced its management will attend the Goldman Sachs Global Healthcare CDMO D...
🔴 Announcement — 15 September 2026Neuland Laboratories announced that its first commercial peptide manufacturing module is now operati...
🔴 Announcement — 9 September 2026Neuland Laboratories announced its management will attend three upcoming investor meetings in Septem...
🟡 Board Meeting — 7 September 2026Neuland Laboratories announced on September 7, 2026, that its board approved ₹126 crores capital exp...

See all NEULANDLAB filings →

🔥 Also filed on 5 August 2026

MAYURUNIQMayur Uniquoters LtdAnnual Report BELBharat Electronics LimitedCorporate Action KIMSKrishna Institute of Medical Sciences LimitedAnnual Report RPTECHRashi Peripherals LimitedFinancial Results RELINFRAReliance Infrastructure LimitedAnnouncement GREAVESCOTGreaves Cotton LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NEULANDLAB files new disclosures

Track NEULANDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.